Merck KGaA gets FDA nod for MS med

 The U.S. FDA has approved EMD Serono's — Merck KGaA's biopharma unit — Mavenclad tablets for the treatment of relapsing forms of multiple sclerosis. Mavenclad offers a new way to treat MS – short treatment…

The Human-Machine Matchup

Combining human reasoning with the machine learning functionality found in advanced analytics applications improves pharma processes By Lisa Graham, PhD and PE, Seed Corporation Apr 01, 2019 When human intuition and experience engage with machine…